<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:12:40Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9899642" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9899642</identifier>
        <datestamp>2023-02-13</datestamp>
        <setSpec>chest</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3-mathml3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Chest</journal-id>
              <journal-id journal-id-type="iso-abbrev">Chest</journal-id>
              <journal-title-group>
                <journal-title>Chest</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0012-3692</issn>
              <issn pub-type="epub">1931-3543</issn>
              <publisher>
                <publisher-name>American College of Chest Physicians</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9899642</article-id>
              <article-id pub-id-type="pmcid">PMC9899642</article-id>
              <article-id pub-id-type="pmc-uid">9899642</article-id>
              <article-id pub-id-type="pmid">36244405</article-id>
              <article-id pub-id-type="pii">S0012-3692(22)03922-8</article-id>
              <article-id pub-id-type="doi">10.1016/j.chest.2022.09.043</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Sleep: Original Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Sleep Arousal-Related Ventricular Repolarization Lability Is Associated With Cardiovascular Mortality in Older Community-Dwelling Men</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au1">
                  <name>
                    <surname>Shahrbabaki</surname>
                    <given-names>Sobhan Salari</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author" id="au2">
                  <name>
                    <surname>Linz</surname>
                    <given-names>Dominik</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <email>dominik.linz@mumc.nl</email>
                  <xref rid="aff2" ref-type="aff">b</xref>
                  <xref rid="aff3" ref-type="aff">c</xref>
                  <xref rid="aff4" ref-type="aff">d</xref>
                  <xref rid="aff5" ref-type="aff">e</xref>
                  <xref rid="cor1" ref-type="corresp">∗</xref>
                </contrib>
                <contrib contrib-type="author" id="au3">
                  <name>
                    <surname>Redline</surname>
                    <given-names>Susan</given-names>
                  </name>
                  <degrees>MD, MPH</degrees>
                  <xref rid="aff6" ref-type="aff">f</xref>
                </contrib>
                <contrib contrib-type="author" id="au4">
                  <name>
                    <surname>Stone</surname>
                    <given-names>Katie</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff7" ref-type="aff">g</xref>
                </contrib>
                <contrib contrib-type="author" id="au5">
                  <name>
                    <surname>Ensrud</surname>
                    <given-names>Kristine</given-names>
                  </name>
                  <degrees>MD, MPH</degrees>
                  <xref rid="aff8" ref-type="aff">h</xref>
                  <xref rid="aff9" ref-type="aff">i</xref>
                </contrib>
                <contrib contrib-type="author" id="au6">
                  <name>
                    <surname>Baumert</surname>
                    <given-names>Mathias</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff1" ref-type="aff">a</xref>
                </contrib>
                <aff id="aff1"><label>a</label>School of Electrical and Electronic Engineering, The University of Adelaide, Adelaide, Australia</aff>
                <aff id="aff2"><label>b</label>Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands</aff>
                <aff id="aff3"><label>c</label>Department of Cardiology, Radboud University Medical Center and Radboud Institute for Health Sciences, Nijmegen, the Netherlands</aff>
                <aff id="aff4"><label>d</label>Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia</aff>
                <aff id="aff5"><label>e</label>Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark</aff>
                <aff id="aff6"><label>f</label>Brigham and Women’s Hospital and Harvard Medical School, Boston, MA</aff>
                <aff id="aff7"><label>g</label>California Pacific Medical Center Research Institute, San Francisco, CA</aff>
                <aff id="aff8"><label>h</label>Department of Medicine and Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN</aff>
                <aff id="aff9"><label>i</label>Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, Minneapolis, MN</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>∗</label><bold>CORRESPONDENCE TO:</bold> Dominik Linz, MD, PhD <email>dominik.linz@mumc.nl</email></corresp>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>13</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <volume>163</volume>
              <issue>2</issue>
              <fpage>419</fpage>
              <lpage>432</lpage>
              <permissions>
                <copyright-statement>© 2022 The Author(s)</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
                </license>
              </permissions>
              <abstract id="abs0010">
                <sec>
                  <title>Background</title>
                  <p>Sleep is fragmented by brief arousals, and excessive arousal burden has been linked to increased cardiovascular (CV) risk, but mechanisms are poorly understood.</p>
                </sec>
                <sec>
                  <title>Research Question</title>
                  <p>Do arousals trigger cardiac ventricular repolarization lability that may predispose people to long-term cardiovascular mortality?</p>
                </sec>
                <sec>
                  <title>Study Design and Methods</title>
                  <p>This study analyzed 407,541 arousals in the overnight polysomnograms of 2,558 older men in the Osteoporotic Fractures in Men sleep study. QT and RR intervals were measured beat-to-beat starting 15 s prior to arousal onset until 15 s past onset. Ventricular repolarization lability was quantified by using the QT variability index (QTVi).</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>During 10.1 ± 2.5 years of follow-up, 1,000 men died of any cause, including 348 CV deaths. During arousals, QT and RR variability increased on average by 5 and 55 ms, respectively, resulting in a paradoxical transient decrease in QTVi from 0.07 ± 1.68 to –1.00 ± 1.68. Multivariable Cox proportional hazards analysis adjusted for age, BMI, cardiovascular and respiratory risk factors, sleep-disordered breathing and arousal, diabetes, and Parkinson disease indicated that excessive QTVi during arousal was independently associated with all-cause and CV mortality (all-cause hazard ratio, 1.20 [95% CI, 1.04-1.38; <italic>P</italic> = .012]; CV hazard ratio, 1.29 [95% CI, 1.01 -1.65; <italic>P</italic> = .043]).</p>
                </sec>
                <sec>
                  <title>Interpretation</title>
                  <p>Arousals affect ventricular repolarization. A disproportionate increase in QT variability during arousal is associated with an increased all-cause and CV mortality and may reflect ventricular repolarization maladaptation to the arousal stimulus. Whether arousal-related QTVi can be used for more tailored risk stratification warrants further study, including evaluating whether arousal suppression attenuates ventricular repolarization lability and reduces subsequent mortality.</p>
                </sec>
                <sec>
                  <title>Clinical Trial Registration</title>
                  <p><ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov" id="interref0010">ClinicalTrials.gov</ext-link>; No.: NCT00070681; URL: <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov" id="intref0010">www.clinicaltrials.gov</ext-link></p>
                </sec>
              </abstract>
              <kwd-group id="kwrds0010">
                <title>Key Words</title>
                <kwd>all-cause mortality</kwd>
                <kwd>cardiovascular mortality</kwd>
                <kwd>QT variability index</kwd>
                <kwd>sleep apnea</kwd>
                <kwd>sleep arousal</kwd>
                <kwd>ventricular repolarization</kwd>
              </kwd-group>
              <kwd-group id="kwrds0015">
                <title>Abbreviations</title>
                <kwd>AHI, apnea-hypopnea index</kwd>
                <kwd>CAD, coronary artery disease</kwd>
                <kwd>CV, cardiovascular</kwd>
                <kwd>CVD, cardiovascular disease</kwd>
                <kwd>MI, myocardial infarction</kwd>
                <kwd>PSG, polysomnogram</kwd>
                <kwd>QTVi, QT variability index</kwd>
                <kwd>REM, rapid eye movement</kwd>
                <kwd>SD<sub>QT</sub>, SD of QT intervals</kwd>
                <kwd>SD<sub>RR</sub>, SD of RR intervals</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <p id="p0010">
              <boxed-text id="dtbox1">
                <caption>
                  <title>Take-home Points</title>
                </caption>
                <p id="p0015"><bold>Study</bold><bold>Q</bold><bold>uestion:</bold> Is ventricular repolarization lability during sleep arousal associated with mortality?</p>
                <p id="p0020"><bold>Results:</bold> Cox proportional hazards models adjusted for confounders show that excessive QT variability during arousal is associated with an increased all-cause and CV mortality in older men.</p>
                <p id="p0025"><bold>Interpretation:</bold> QT variability may be an effective marker of cardiac maladaptation to arousal stimuli during sleep.</p>
              </boxed-text>
            </p>
            <p id="p0030">Sleep is fragmented by brief intrusions of unconscious wakefulness, so-called cortical arousals, which last between 3 and 15 s and are a normal feature of sleep.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Sleep arousals can occur spontaneously or in response to sleep-disordered breathing, periodic limb movements, trauma, pain, temperature, light, and noise. Importantly, excessive nocturnal arousal burden (ie, &gt; 8.5% and &gt; 6.5% arousal time relative to total sleep time in men and women, respectively) is associated with long-term cardiovascular (CV) and all-cause mortality.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref></p>
            <p id="p0035">CV responses to sleep arousal may explain, at least in part, the association between sleep arousals and mortality observed in epidemiologic studies.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Irrespective of the underlying trigger,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> individual sleep arousals may elicit an acute transient activation of the autonomic nervous system and hemodynamic changes, including surges in sympathetic nerve activity and a combined volume and pressure overload.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> All of these arousal-related responses have been individually linked to worse CV outcomes,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> but none of them is currently incorporated into the clinical assessment of episodic arousals, which exclusively considers cortical activation via EEG traces on overnight polysomnography.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref></p>
            <p id="p0040">Autonomic and hemodynamic alterations critically determine ventricular repolarization reflected in the T wave on an ECG. The QT interval, a global marker of ventricular repolarization duration, can be tracked on the ECG channel of a standard polysomnogram (PSG) to quantify the transient CV response to individual sleep arousals. Beat-to-beat variability in the QT interval captures transient dynamics in ventricular repolarization, yielding a simple, noninvasive marker of repolarization lability predictive of sudden arrhythmia death.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> In particular, when normalized to heart rate variability, the so-called QT variability index (QTVi) has been established as a powerful predictor of CV mortality in several patient populations.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> The quantification of arousal-related CV responses has the potential for a more disease-oriented and pathophysiology-based assessment of sleep-related abnormalities.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> It may provide the foundation for a better-tailored sleep arousal-specific risk stratification. Because high-fidelity computer algorithms for fully automated precise QT interval measurement are available,<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> it could be incorporated into a clinical PSG assessment.</p>
            <p id="p0045">We hypothesized that the intensity of cardiac repolarization lability elicited by arousals identifies patients at risk for increased mortality. The objective of the current study therefore was to determine the QT variability in response to arousal in a large sample population of older men and its association with long-term CV and all-cause mortality.</p>
            <sec id="sec1">
              <title>Study Design and Methods</title>
              <sec id="sec1.1">
                <title>Study Population</title>
                <p id="p0050">We studied participants of the Osteoporotic Fractures in Men (MrOS) observational cohort study that enrolled 5,995 community-dwelling men aged &gt; 65 years to investigate the epidemiology of osteoporosis in older men and identify the risk factors for fracture and bone loss.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref> Of the 5,995 MrOS participants, 2,860 men in the main cohort did not participate in the sleep study visit (1,995 were unwilling to participate, 421 did not undergo screening because recruitment goals were met, 270 died prior to the sleep study visit, 150 were ineligible because they were receiving therapy for sleep apnea [CPAP or oxygen], and 24 were terminated prior to the sleep study visit).<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> Thus, 3,135 men participated in the MrOS sleep study and completed an examination that included a clinic visit and overnight in-home overnight PSG, including a single-channel ECG.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> Of these men, 2,892 (92.2%) had technically adequate PSG, while another 196 men were excluded because of insufficient ECG quality. A flowchart of participants included in the study is presented in <xref rid="mmc1" ref-type="supplementary-material">e-Figure 1</xref>.</p>
              </sec>
              <sec id="sec1.2">
                <title>Follow-up</title>
                <p id="p0055">MrOS sleep participants were followed up via postcards and/or telephone every 4 months to survey for recent hospitalizations or medical treatment for CV disease (CVD) or clinically relevant arrhythmia requiring medical attention; the study had a <italic>&gt;</italic> 99% response rate. A board-certified cardiologist verified all relevant medical records and supporting documents for centralized adjudication using a prespecified protocol.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> The death certificate and hospital records from the time of death were collected for fatal events. If a fatal event did not occur at the hospital, a proxy interview with the next of kin and the participant’s most recent hospitalization documents in the prior 12 months were collected. Only events confirmed by the adjudicator were included for analysis.</p>
              </sec>
              <sec id="sec1.3">
                <title>In-Home Overnight PSG and Sleep Scoring</title>
                <p id="p0060">Sleep recordings were performed by using an unattended, portable in-home PSG over 1 night at the participant’s residence using the Safiro Sleep Monitoring System (Compumedics) for the MrOS sleep study. Trained staff members visited the participants to attach the sensors and electrodes and conduct overnight PSG. The setup included two central EEGs, bilateral electrooculograms, bilateral chin electromyogram, a bipolar ECG, nasal-oral thermistor, nasal flow via a pressure transducer and nasal cannula, abdominal and respiratory inductance plethysmography, finger pulse oximetry, bilateral leg movements by piezoelectric sensors, and body position.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref></p>
                <p id="p0065">Research sleep technicians at a central sleep reading center, blinded to all other data, scored arousals along with other typical sleep events such as limb movements, respiratory events, and body movement, following the standard criteria defined by the American Academy of Sleep Medicine<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> and described previously in detail.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Interscorer and intrascorer reliability for all key indexes exceeded 0.90.</p>
              </sec>
              <sec id="sec1.4">
                <title>Ventricular Repolarization Measurement</title>
                <p id="p0070">In 2,558 men, a total of 407,541 arousal episodes were observed, on average 159 events (27 per hour) per participant. For every arousal, beat-to-beat RR and QT intervals were automatically extracted from the ECG channel of the PSG using our validated two-dimensional signal-warping algorithm that tracks QT changes with high precision (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 2</xref>).<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Although QT variability can be observed on any ECG lead, leads with tall T waves, such as lead II, recorded during PSG, are preferable due to a better signal-to-noise ratio.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref></p>
                <p id="p0075">The 15 s prior to every arousal onset were extracted to capture the baseline characteristics in the ECG. Because the cardiac response elicited by brief sympathetic activation, such as caused by arousal, largely diminishes within 10 s, and most arousals do not exceed a few seconds, the 15 s following arousal onset were captured. To investigate the effect of arousal on repolarization in detail, we measured both QT and RR intervals beat-to-beat across three 10 s time windows: (1) baseline period, –15 to –5 s prior to arousal onset detected in the central EEG channels; (2) arousal onset, –5 s prior to arousal onset to 5 s following arousal onset; and (3) postarousal onset, 5 to 15 s following arousal onset.</p>
                <p id="p0080">To quantify the ventricular repolarization dynamics prior to, during, and following arousal onset, we computed the QT variability index (QTVi):<disp-formula id="ufd1"><mml:math id="M1" altimg="si1.svg"><mml:mrow><mml:mi>Q</mml:mi><mml:mi>T</mml:mi><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>21</mml:mn><mml:mi>n</mml:mi><mml:mfrac><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>Q</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>Q</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mfrac></mml:mrow></mml:math></disp-formula></p>
                <p id="p0085">where SD<sub>QT</sub>, M<sub>QT</sub>, SD<sub>RR</sub> and M<sub>RR</sub> here represent the mean and SD of QT and RR intervals for each arousal. Because both QT and RR variability are measured in units of milliseconds, QTVi is dimensionless. Owing to the logarithm in the definition of QTVi, values &lt; 0 indicate greater RR variability relative to QT variability, whereas QTVi &gt; 0 represents higher QT variability than RR variability.</p>
              </sec>
              <sec id="sec1.5">
                <title>Other Measures</title>
                <p id="p0090">All participants were required to attend a clinical interview and complete an enrollment form containing a questionnaire on medical history in advance of overnight PSG recordings. The participants’ race/ethnicity, BMI, and history of physician diagnosis of diabetes, hypertension, coronary artery disease (CAD), myocardial infarction (MI), congestive heart failure, transient ischemic attack, asthma, COPD, Parkinson disease, atrial fibrillation, and stroke were surveyed. Furthermore, participants reported smoking habits and alcohol consumption and completed the Physical Activity Scale for the Elderly questionnaire. Arterial BP was measured during the clinical visit. From overnight PSG, we derived the mean respiratory rate,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> the time of sleep spent below 90% oxygen saturation,<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> the apnea-hypopnea index (AHI), the arousal index, arousal burden,<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> and the periodic limb movement index.</p>
              </sec>
              <sec id="sec1.6">
                <title>Statistical Analysis</title>
                <p id="p0095">QTVi values were divided into quartiles for Kaplan-Meier curve survival analysis and log-rank testing. Anthropometric data, lifestyle metrics, and medical history were compared by using dichotomized variables, <italic>t</italic> test, and χ<sup>2</sup> test. A repeated measures analysis of variance was performed to evaluate variables prior to, during, and following the onset of arousal. We used restricted cubic splines with knots at the 5th, 35th, 65th, and 95th percentiles to explore the potential nonlinear association of the continuous variables with the outcome. Association between exposure variables (continuous and quartiles) and mortality were established with Cox proportional hazards models. The hazard ratio (HR) proportionality was determined by using cumulative sums of martingale residuals. Cumulative incidence function and Fine-Gray subdistribution hazard models were applied to predict CV death in the presence of competing risks of non-CV death. In all statistical tests, a <italic>P</italic> value of .05 was considered statistically significant.</p>
                <p id="p0100">MATLAB (R2020a, MathWorks) and Python libraries such as Lifelines and SciPy (Python Software Foundation) were used for computing and statistical analysis.</p>
              </sec>
            </sec>
            <sec id="sec2">
              <title>Results</title>
              <sec id="sec2.1">
                <title>Participant Characteristics</title>
                <p id="p0105">At the baseline visit, MrOS cohort participants were on average 76.3 ± 5.5 years old and had a BMI of 27.2 ± 3.8 kg/m<sup>2</sup>; almost one-half of the men were overweight (<xref rid="tbl1" ref-type="table">Table 1</xref>). About 16% of men had CAD/MI, and almost 6% had heart failure. Overnight PSG revealed that AHI, arousal index and arousal burden values were 19.9 ± 12.8 h<sup>–1</sup>, 25.1 ± 12.5 h<sup>–1</sup>, and 6.6% ± 3.2%, respectively.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Cohort Characteristics of Osteoporotic Fractures (MrOS) Based on Arousal-Related QTVi Quartiles</p></caption><table frame="hsides" rules="groups"><thead><tr><th><break/>Variable</th><th>All Subjects (N = 2,558)</th><th>QTVi &lt; 0.42 (Q1-Q3)<break/>(n = 1,918)</th><th>QTVi ≥ 0.42 (Q4)<break/>(n = 640)</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age, y</td><td align="char">76.3 ± 5.5</td><td align="char">76.2 ± 5.5</td><td align="char">76.5 ± 5.6</td><td align="char">.256</td></tr><tr><td>Race</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> White</td><td align="char">2,336 (91.3)</td><td align="char">1,739 (90.7)</td><td align="char">597 (93.3)</td><td align="char">.051</td></tr><tr><td> Black</td><td align="char">79 (3.1)</td><td align="char">58 (3.0)</td><td align="char">21 (3.3)</td><td align="char">.846</td></tr><tr><td> Asian</td><td align="char">79 (3.1)</td><td align="char">71 (3.7)</td><td align="char">8 (1.2)</td><td align="char"><bold>.003</bold></td></tr><tr><td> Other</td><td align="char">64 (2.5)</td><td align="char">50 (2.6)</td><td align="char">14 (2.2)</td><td align="char">.658</td></tr><tr><td>Body weight</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> BMI, kg/m<sup>2</sup></td><td align="char">27.2 ± 3.8</td><td align="char">27.1 ± 3.7</td><td align="char">27.5 ± 4.1</td><td align="char"><bold>.019</bold></td></tr><tr><td> Overweight</td><td align="char">1,276 (49.9)</td><td align="char">957 (49.9)</td><td align="char">319 (49.8)</td><td align="char">.982</td></tr><tr><td> Obese</td><td align="char">525 (20.5)</td><td align="char">393 (20.5)</td><td align="char">132 (20.6)</td><td align="char">.987</td></tr><tr><td>Cardiac assessment</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> Atrial fibrillation</td><td align="char">258 (10.1)</td><td align="char">160 (8.3)</td><td align="char">98 (15.3)</td><td align="char"><bold>&lt; .001</bold></td></tr><tr><td> SBP, mm Hg</td><td align="char">126.5 ± 17</td><td align="char">126.4 ± 17</td><td align="char">126.7 ± 17</td><td align="char">.730</td></tr><tr><td> DBP, mm Hg</td><td align="char">67.5 ± 9.4</td><td align="char">67.4 ± 9.4</td><td align="char">67.7 ± 9.3</td><td align="char">.499</td></tr><tr><td>Lifestyle</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> Smoking</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> Never</td><td align="char">1,019 (40)</td><td align="char">764 (39.8)</td><td align="char">255 (39.8)</td><td align="char">.966</td></tr><tr><td> Past</td><td align="char">1,489 (58.2)</td><td align="char">1,116 (58.2)</td><td align="char">373 (58.3)</td><td align="char">.996</td></tr><tr><td> Current</td><td align="char">50 (1.9)</td><td align="char">38 (2.0)</td><td align="char">12 (1.9)</td><td align="char">.997</td></tr><tr><td> Current alcohol consumers</td><td align="char">1,687 (66)</td><td align="char">1,193 (62.2)</td><td align="char">493 (77.0)</td><td align="char"><bold>&lt; .001</bold></td></tr><tr><td> PASE score</td><td align="char">146.4 ± 71.2</td><td align="char">148.5 ± 71.6</td><td align="char">140.2 ± 69.8</td><td align="char"><bold>.011</bold></td></tr><tr><td>Medical history</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> Stroke</td><td align="char">87 (3.4)</td><td align="char">63 (3.3)</td><td align="char">24 (3.8)</td><td align="char">.663</td></tr><tr><td> CAD/MI</td><td align="char">418 (16.3)</td><td align="char">281 (14.7)</td><td align="char">137 (21.4)</td><td align="char"><bold>&lt; .001</bold></td></tr><tr><td> CHF</td><td align="char">151 (5.9)</td><td align="char">96 (5.0)</td><td align="char">55 (8.6)</td><td align="char"><bold>.001</bold></td></tr><tr><td> TIA</td><td align="char">233 (9.1)</td><td align="char">163 (8.5)</td><td align="char">70 (10.9)</td><td align="char">.075</td></tr><tr><td> Asthma</td><td align="char">202 (7.9)</td><td align="char">151 (7.9)</td><td align="char">51 (8.0)</td><td align="char">.994</td></tr><tr><td> COPD</td><td align="char">136 (5.3)</td><td align="char">100 (5.2)</td><td align="char">36 (5.6)</td><td align="char">.764</td></tr><tr><td> HTN</td><td align="char">1271(49.7)</td><td align="char">938 (48.9)</td><td align="char">333 (52)</td><td align="char">.186</td></tr><tr><td> Diabetes</td><td align="char">328 (12.8)</td><td align="char">237 (12.4)</td><td align="char">91 (14.2)</td><td align="char">.249</td></tr><tr><td> Parkinson disease</td><td align="char">27 (1.1)</td><td align="char">18 (0.9)</td><td align="char">9 (1.4)</td><td align="char">.436</td></tr><tr><td>Overnight polysomnography</td><td align="char"/><td align="char"/><td align="char"/><td align="char"/></tr><tr><td> AHI, h<sup>–1</sup></td><td align="char">19.9 ± 12.8</td><td align="char">19.9 ± 13</td><td align="char">20.0 ± 12.4</td><td align="char">.956</td></tr><tr><td> AI, h<sup>–1</sup></td><td align="char">25.1 ± 12.5</td><td align="char">25.0 ± 12.4</td><td align="char">25.4 ± 12.7</td><td align="char">.456</td></tr><tr><td> AB, %</td><td align="char">6.6 ± 3.2</td><td align="char">6.6 ± 3.4</td><td align="char">6.6 ± 3.2</td><td align="char">.728</td></tr><tr><td> PLMI, h<sup>–1</sup></td><td align="char">10.6 ± 10</td><td align="char">10.5 ± 9.6</td><td align="char">10.9 ± 11.1</td><td align="char">.356</td></tr><tr><td> MRR, min<sup>–1</sup></td><td align="char">14.8 ± 1.9</td><td align="char">14.7 ± 1.8</td><td align="char">14.9 ± 1.7</td><td align="char"><bold>.049</bold></td></tr><tr><td> T90, min</td><td align="char">14.2 ± 32.6</td><td align="char">13.6 ± 31.5</td><td align="char">15.9 ± 35.8</td><td align="char">.118</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean ± SD or No. (%). Boldface indicates a <italic>P</italic> value with statistical significance. AB = arousal burden; AHI = apnea/hypopnea index; AI = arousal index; CAD = coronary artery disease; CHF = congestive heart failure; DBP = diastolic BP; HTN = hypertension; MI = myocardial infarction; MrOS = Osteoporotic Fractures in Men; MRR = mean respiratory rate; PASE = Physical Activity Scale for Elderly; PLMI = periodic limb movement index; QTVi = QT variability index; SBP = systolic BP; T90 = time of sleep spent below 90% oxygen saturation; TIA = transient ischemic attack.</p></fn></table-wrap-foot></table-wrap></p>
                <p id="p0110">Participants in the highest QTVi quartile were more likely to have a slightly greater BMI, consume alcohol, be less physically active, have a faster mean respiratory rate, and have a history of atrial fibrillation, congestive heart failure, and MI/CAD. <xref rid="mmc1" ref-type="supplementary-material">e-Table 1</xref> presents the men’s characteristics dichotomized on the highest quartile of QT and RR variance (SD<sub>QT</sub> and SD<sub>RR</sub>).</p>
              </sec>
              <sec id="sec2.2">
                <title>Repolarization Variability During Arousal</title>
                <p id="p0115"><xref rid="fig1" ref-type="fig">Figure 1</xref>A illustrates the transient ECG changes during cortical arousal. Across the entire cohort, QTVi significantly decreased from 0.07 ± 1.68 to –1.00 ± 1.68 at arousal onset and gradually recovered within 5 to 10 s following arousal onset (–0.39 ± 1.45<italic>; P</italic> &lt; .001) (<xref rid="fig1" ref-type="fig">Fig 1</xref>D). Assessing the contributions of RR and QT interval variability individually, both significantly increased during arousal (baseline SD<sub>QT</sub>, 14 ± 10 ms; arousal SD<sub>QT</sub>, 19 ± 11 ms; baseline SD<sub>RR</sub>, 71 ± 66 ms; arousal SD<sub>RR</sub>, 126 ± 71 ms) (<xref rid="fig1" ref-type="fig">Figs 1</xref>B, <xref rid="fig1" ref-type="fig">1</xref>C). The relative increase in RR variability was more pronounced than the QT variability (77% ± 7.5% vs 36% ± 10%), resulting in a transient paradoxical QTVi decrease.<fig id="fig1"><label>Figure 1</label><caption><p>A, Graphical example of ECG and EEG activation during an arousal episode. Heart period and repolarization variability prior to (B), during (C), and following (D) the onset of arousal from sleep. P value indicates the repeated measures analysis of variance results. SD<sub>QT</sub> and SD<sub>RR</sub> = QT and RR variance; QTVi = QT variability index.</p></caption><graphic xlink:href="gr1"/></fig></p>
                <p id="p0120">Investigating the effect of arousal trigger on repolarization lability, respiratory event-related arousals caused significantly higher QTVi than nonrespiratory arousals (0.23 ± 0.89 vs –0.33 ± 0.68; <italic>P</italic> &lt; .001); baseline QTVi was comparable (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 3</xref>).</p>
                <p id="p0125">Comparing arousal responses during rapid eye movement (REM) sleep with non-REM sleep, QTVi during arousal was higher in non-REM sleep than in REM sleep (–0.68 ± 0.59 vs –0.77 ± 0.61; <italic>P</italic> &lt; .001); baseline QTVi was similar (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 4</xref>).</p>
                <p id="p0130">QTVi was only marginally influenced by arousal duration index (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 5</xref>) and arousal frequency (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 6</xref>).</p>
              </sec>
              <sec id="sec2.3">
                <title>CV and All-Cause Mortality</title>
                <p id="p0135">End point data were available for 2,558 participants (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 1</xref>). During the mean ± SD follow-up period of 10.1 ± 2.5 years, 1,000 (39.1%) men died of any cause, including 348 (34.8%) confirmed CV deaths, 42 (4.7%) deaths from stroke, 249 (24.9%) deaths from cancer, and 81 (8.1%) pulmonary disease deaths. A total of 322 (32.2%) deaths were adjudicated as due to causes other than cancer, CVD, and pulmonary disease.</p>
              </sec>
              <sec id="sec2.4">
                <title>Univariate and Multivariate Survival Analyses</title>
                <p id="p0140">Although prearousal QTVi was not significantly associated with mortality outcomes (<xref rid="fig2" ref-type="fig">Figs 2</xref>A, <xref rid="fig2" ref-type="fig">2</xref>B), the QTVi response to arousal onset was modestly associated with increased overall mortality (<xref rid="fig2" ref-type="fig">Figs 2</xref>C, <xref rid="fig2" ref-type="fig">2</xref>E). Subsequently, we dichotomized QTVi values on the fourth quartile of arousal onset QTVi to compare CV vs non-CV mortality risks. Augmented QTVi in response to arousal increased the probability of CV mortality by about 7% compared with men in the lower three QTVi quartiles (<xref rid="fig2" ref-type="fig">Fig 2</xref>D). The association between the highest QTVi quartile and CV mortality faded following arousal onset (<xref rid="fig2" ref-type="fig">Fig 2</xref>F). QTVi was not associated with non-CV mortality.<fig id="fig2"><label>Figure 2</label><caption><p>QTVi and mortality. All-cause mortality across QTVi quartiles at baseline (A), arousal onset (C), and postarousal onset (E). Cumulative incident function curves comparing the competing risk of CV and non-CV mortality of dichotomized QTVi at baseline (B), arousal onset (D), and postarousal onset (F). QTVi values were dichotomized using the fourth quartile of the arousal onset QTVi distribution. P value shows log-rank test results. CV = cardiovascular; Q1-Q4 = quartiles of the QT variability index for Baseline QTVi, Arousal onset QTVi and Post Arousal onset QTVi; QTVi = QT variability index.</p></caption><graphic xlink:href="gr2"/></fig></p>
                <p id="p0145">We developed univariate and multivariable Cox proportional regression models for QTVi prior to, during, and following arousal onset to assess associations with all-cause, CV, and non-CV mortality (<xref rid="tbl2" ref-type="table">Table 2</xref>). Continuous QTVi was significantly associated with CV mortality prior to, during, and following arousal onset in univariate Cox proportional hazards analysis. Associations were modest in magnitude (HR, 1.81-3.47 per 1 SD increase in QTVi). After adjusting the Cox proportional hazards regression model for age, BMI category, history of hypertension, MI/CAD, atrial fibrillation, congestive heart failure, stroke, diabetes, transient ischemic attack, Parkinson disease, asthma and COPD, drinking and smoking habits, arousal index, arousal burden, apnea/hypopnea index, mean respiratory rate, time spent with oxygen desaturation below 90%, and the average rate-corrected QT interval, continuous QTVi in response to arousal (but not QTVi at baseline) remained independently associated with all-cause mortality (HR, 1.47; 95% CI, 1.07-2.02; <italic>P</italic> = .029) and CV mortality (HR, 2.47; 95% CI, 1.43-4.25; <italic>P</italic> = .001), both expressed as per SD of QTVi. Forrest plot analysis (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 7</xref>) shows that the QT component rather than the RR component of QTVi is the primary driver of the association with CV mortality. Age (HR, 1.07; 95% CI, 1.05-1.10; <italic>P</italic> &lt; .001), history of atrial fibrillation (HR, 1.79; 1.33-2.40; <italic>P</italic> &lt; .001), CAD/MI (HR, 1.49; 95% CI, 1.14-1.90; <italic>P</italic> = .003), and diabetes (HR, 1.51; 95% CI, 1.12-2.00; <italic>P</italic> = .006), as well as mean respiratory rate (HR, 1.07; 95% CI, 1.00-1.10; <italic>P</italic> = .047), were significant CV outcome predictors in the model. We found no evidence of associations of QTVi prior to, during, or following arousal with the risk of non-CVD mortality.<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Association of QT and RR Time Intervals Variables Prior to, During, and Following Arousals With All-Cause and Cardiovascular Mortality</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Variables</th><th colspan="4">All-Cause Mortality (n = 1,000)<hr/></th><th colspan="4">Cardiovascular Mortality (n = 348)<hr/></th><th colspan="4">Noncardiovascular Mortality (n = 552)<hr/></th></tr><tr><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th></tr><tr><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Prior to arousal</td><td/><td align="char"/><td/><td/><td/><td align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td> QTVi (SD)</td><td>1.19 (0.86-1.64)</td><td align="char">.287</td><td>1.20 (0.85-1.71)</td><td align="center">.321</td><td>1.81 (1.06-2.18)</td><td align="char"><bold>.029</bold></td><td>1.66 (0.94-2.95)</td><td align="center">.088</td><td>0.95 (0.63-1.41)</td><td align="center">.789</td><td>1.01 (0.65-1.56)</td><td align="center">.978</td></tr><tr><td> QTVi ≥ 0.42</td><td>1.03 (0.91-1.17)</td><td align="char">.616</td><td>1.09 (0.95-1.25)</td><td align="center">.238</td><td>1.19 (0.96-1.46)</td><td align="char">.115</td><td>1.23 (0.98-1.55)</td><td align="center">.074</td><td>0.96 (0.82-1.12)</td><td align="center">.593</td><td>1.02 (0.86-1.21)</td><td align="center">.861</td></tr><tr><td>Arousal onset</td><td/><td align="char"/><td/><td/><td/><td align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td> QTVi (SD)</td><td>1.80 (1.35-2.41)</td><td align="char"><bold>&lt; .001</bold></td><td>1.47 (1.07-2.02)</td><td align="center"><bold>.029</bold></td><td>3.47 (2.11-5.72)</td><td align="char"><bold>&lt; .001</bold></td><td>2.47 (1.43-4.25)</td><td align="center"><bold>.001</bold></td><td>1.28 (0.89-1.82)</td><td align="center">.169</td><td>1.12 (0.76-1.67)</td><td align="center">.693</td></tr><tr><td> QTVi ≥ 0.42</td><td>1.25 (1.09-1.43)</td><td align="char"><bold>.001</bold></td><td>1.20 (1.04-1.38)</td><td align="center"><bold>.012</bold></td><td>1.49 (1.19-1.86)</td><td align="char"><bold>&lt; .001</bold></td><td>1.29 (1.01-1.65)</td><td align="center"><bold>.043</bold></td><td>1.13 (0.95-1.34)</td><td align="center">.161</td><td>1.11 (0.92-1.32)</td><td align="center">.279</td></tr><tr><td>Postarousal onset</td><td/><td align="char"/><td/><td/><td/><td align="char"/><td/><td/><td/><td/><td/><td/></tr><tr><td> QTVi (SD)</td><td>1.68 (1.15-2.44)</td><td align="char"><bold>.007</bold></td><td>1.37 (0.90-2.07)</td><td align="center">.138</td><td>3.02 (1.59-5.72)</td><td align="char"><bold>&lt; .001</bold></td><td>2.09 (1.04-4.18)</td><td align="center"><bold>.039</bold></td><td>1.23 (0.77-1.95)</td><td align="center">.385</td><td>1.10 (0.66-1.85)</td><td align="center">.763</td></tr><tr><td> QTVi ≥ 0.42</td><td>1.05 (0.92-1.20)</td><td align="char">.455</td><td>1.02 (0.89-1.19)</td><td align="center">.745</td><td>1.17 (0.94-1.46)</td><td align="char">.159</td><td>1.05 (0.83-1.34)</td><td align="center">.668</td><td>0.99 (0.84-1.17)</td><td align="center">.916</td><td>1.01 (0.84-1.22)</td><td align="center">.883</td></tr></tbody></table><table-wrap-foot><fn><p>Multivariable analysis was adjusted for age, history of stroke, atrial fibrillation, myocardial infarction/coronary artery disease, congestive heart failure, transient ischemic attack, diabetes, hypertension, COPD, asthma and Parkinson disease, mean heart rate, mean respiratory rate, Physical Activity Scale for Elderly, systolic and diastolic BPs, time of sleep spent below 90% oxygen saturation, BMI, apnea-hypopnea index, arousal index, average corrected QT, arousal burden, and drink and smoking habit. QT variability index (QTVi) values were dichotomized at the 75th percentile of the arousal-onset QTVi. Boldface indicates a <italic>P</italic> value with statistical significance. HR = hazard ratio.</p></fn></table-wrap-foot></table-wrap></p>
                <p id="p0150">The exposure-response analysis shows the nonlinear association of QTVi at arousal with CV mortality adjusted for confounders (<xref rid="fig3" ref-type="fig">Fig 3</xref>). The risk of CV mortality gradually increased with an increase in QTVi beyond –1. <xref rid="mmc1" ref-type="supplementary-material">e-Figure 8</xref> further illustrates the association between QTVi quartiles and CV mortality. To remove the effect of atrial fibrillation from the analysis, we subsequently only considered participants with no history of atrial fibrillation. The Cox model confirmed the significant association between increased QTVi at arousal onset and CV mortality (continuous HR, 1.26 [95% CI, 1.12-1.43; <italic>P</italic> &lt; .001]; dichotomous HR, 1.32 [95% CI, 1.02–1.69; <italic>P</italic> = .036) (<xref rid="appsec1" ref-type="sec">e-Table 2</xref>). In particular, the QT component of QTVi, age, CAD/MI, diabetes, physical activity, and AHI were predictive in people with no history of atrial fibrillation (<xref rid="mmc1" ref-type="supplementary-material">e-Fig 9</xref>).<fig id="fig3"><label>Figure 3</label><caption><p>The exposure-response relationship of arousal-related QTVi and CV mortality adjusted for age, history of stroke, myocardial infarction/coronary artery disease, atrial fibrillation, congestive heart failure, diabetes, hypertension, COPD, asthma, mean heart rate, mean respiratory rate, Physical Activity Scale for Elderly, systolic and diastolic blood pressures, time of sleep spent below 90% oxygen saturation, BMI, apnea-hypopnea index, arousal index, average corrected QT, arousal burden, and drink and smoking habit. CV = cardiovascular; QTVi = QT variability index.</p></caption><graphic xlink:href="gr3"/></fig></p>
              </sec>
              <sec id="sec2.5">
                <title>Subgroup Analyses</title>
                <p id="p0155">To validate the effect of arousal on ventricular repolarization lability and its association with mortality, we investigated the subgroup of men whose QTVi was in the lowest quartile during baseline; that is, considered normal but increased beyond the first quartile during arousal. Men who developed larger QTVi responses during arousal were older; had a higher BMI, lower physical activity, and a history of atrial fibrillation; and were more likely to have severe sleep apnea (<xref rid="tbl3" ref-type="table">Table 3</xref>). The risk of CV death was about 9% greater in men whose QTVi increased to arousal (<italic>P</italic> = .007) (<xref rid="fig4" ref-type="fig">Fig 4</xref>). Univariate and multivariable analyses confirmed the association between an arousal-related QTVi increase and CV mortality (HR, 2.02 [95% CI, 1.25-3.26; <italic>P</italic> = .004]; HR, 1.89 [95% CI, 1.14-3.14; <italic>P</italic> = .013]) (<xref rid="tbl4" ref-type="table">Table 4</xref>). There was no significant association between adjusted QTVi and non-CV mortality in this subgroup.<table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Characteristics of the Sample With a Baseline QTVi Within the First QTVi Quartile</p></caption><table frame="hsides" rules="groups"><thead><tr><th><break/>Variable</th><th>All Subjects (N = 640)</th><th>Arousal QTVi Less Than –0.96 (Q1)<break/>(n = 417)</th><th>Arousal QTVi Equal to Greater Than –0.96 (Q2-Q4)<break/>(n = 233)</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age, y</td><td align="center">76.2 ± 5.4</td><td align="center">75.8 ± 5.2</td><td align="center">76.8 ± 5.6</td><td align="char"><bold>.025</bold></td></tr><tr><td> White</td><td align="center">579 (90.5)</td><td align="center">372 (89.2)</td><td align="center">207 (92.8)</td><td align="char">.179</td></tr><tr><td> African-American</td><td align="center">19 (3.0)</td><td align="center">10 (2.4)</td><td align="center">9 (4.0)</td><td align="char">.358</td></tr><tr><td> Asian</td><td align="center">26 (4.1)</td><td align="center">22 (5.3)</td><td align="center">4 (1.8)</td><td align="char">.055</td></tr><tr><td> Other</td><td align="center">16 (2.5)</td><td align="center">13 (3.1)</td><td align="center">3 (1.3)</td><td align="char">.270</td></tr><tr><td>Body weight</td><td/><td/><td/><td align="char"/></tr><tr><td> BMI, kg/m<sup>2</sup></td><td align="center">26.8 ± 3.6</td><td align="center">26.5 ± 3.5</td><td align="center">27.2 ± 3.6</td><td align="char"><bold>.011</bold></td></tr><tr><td> Overweight</td><td align="center">315 (49.2)</td><td align="center">213 (51.1)</td><td align="center">102 (45.7)</td><td align="char">.228</td></tr><tr><td> Obese</td><td align="center">124 (19.4)</td><td align="center">69 (16.5)</td><td align="center">55 (24.7)</td><td align="char"><bold>.018</bold></td></tr><tr><td>Cardiac assessment</td><td/><td/><td/><td align="char"/></tr><tr><td> Atrial fibrillation</td><td align="center">44 (6.9)</td><td align="center">13 (3.1)</td><td align="center">31 (13.9)</td><td align="char"><bold>&lt; .001</bold></td></tr><tr><td> SBP, mm Hg</td><td align="center">127.0 ± 16.2</td><td align="center">126.7 ± 15.9</td><td align="center">127.5 ± 16.6</td><td align="char">.561</td></tr><tr><td> DBP, mm Hg</td><td align="center">67.3 ± 9.4</td><td align="center">67.4 ± 9.1</td><td align="center">67.1 ± 9.8</td><td align="char">.642</td></tr><tr><td>Lifestyle</td><td/><td/><td/><td align="char"/></tr><tr><td> Smoking</td><td/><td/><td/><td align="char"/></tr><tr><td> Never</td><td align="center">237 (37)</td><td align="center">150 (36.0)</td><td align="center">87 (39.0)</td><td align="char">.501</td></tr><tr><td> Past</td><td align="center">388 (60.6)</td><td align="center">257 (61.6)</td><td align="center">131 (58.7)</td><td align="char">.531</td></tr><tr><td> Current</td><td align="center">15 (2.3)</td><td align="center">10 (2.4)</td><td align="center">5 (2.2)</td><td align="char">.881</td></tr><tr><td> Current alcohol consumers</td><td align="center">431 (67.3)</td><td align="center">281 (67.4)</td><td align="center">150 (67.3)</td><td align="char">.954</td></tr><tr><td> PASE score</td><td align="center">152.5 ± 69.8</td><td align="center">156.5 ± 70.6</td><td align="center">144.9 ± 67.6</td><td align="char"><bold>.049</bold></td></tr><tr><td>Medical history</td><td/><td/><td/><td align="char"/></tr><tr><td> Stroke</td><td align="center">23 (3.6)</td><td align="center">15 (3.6)</td><td align="center">8 (3.6)</td><td align="char">.829</td></tr><tr><td> CAD/MI</td><td align="center">88 (13.8)</td><td align="center">59 (14.1)</td><td align="center">29 (13.0)</td><td align="char">.779</td></tr><tr><td> CHF</td><td align="center">23 (3.9)</td><td align="center">13 (3.1)</td><td align="center">12 (5.4)</td><td align="char">.232</td></tr><tr><td> TIA</td><td align="center">57 (8.9)</td><td align="center">32 (7.7)</td><td align="center">25 (11.2)</td><td align="char">.177</td></tr><tr><td> Asthma</td><td align="center">60 (9.4)</td><td align="center">35 (8.4)</td><td align="center">25 (11.2)</td><td align="char">.306</td></tr><tr><td> COPD</td><td align="center">33 (5.2)</td><td align="center">16 (3.8)</td><td align="center">17 (7.6)</td><td align="char">.060</td></tr><tr><td> HTN</td><td align="center">313 (48.9)</td><td align="center">197 (47.2)</td><td align="center">116 (52.0)</td><td align="char">.285</td></tr><tr><td> Diabetes</td><td align="center">87 (13.6)</td><td align="center">55 (13.2)</td><td align="center">32 (14.3)</td><td align="char">.774</td></tr><tr><td> Parkinson disease</td><td align="center">6 (0.9)</td><td align="center">4 (1.0)</td><td align="center">2 (0.9)</td><td align="char">.724</td></tr><tr><td>Overnight polysomnography</td><td/><td/><td/><td align="char"/></tr><tr><td> AHI, h<sup>–1</sup></td><td align="center">18.7 ± 12.3</td><td align="center">18.0 ± 12</td><td align="center">20.0 ± 12.7</td><td align="char"><bold>.049</bold></td></tr><tr><td> AI, h<sup>–1</sup></td><td align="center">24.0 ± 11.6</td><td align="center">24.0 ± 11.1</td><td align="center">24.0 ± 12.5</td><td align="char">.997</td></tr><tr><td> AB, %</td><td align="center">6.3 ± 3.1</td><td align="center">6.2 ± 2.9</td><td align="center">6.6 ± 3.5</td><td align="char">.077</td></tr><tr><td> PLMI, h<sup>–1</sup></td><td align="center">10.8 ± 8.4</td><td align="center">11.0 ± 8.8</td><td align="center">10.4 ± 7.7</td><td align="char">.414</td></tr><tr><td> MRR, min<sup>–1</sup></td><td align="center">14.7 ± 1.9</td><td align="center">14.6 ± 1.8</td><td align="center">14.7 ± 1.9</td><td align="char">.501</td></tr><tr><td> T90, min</td><td align="center">12.2 ± 31.5</td><td align="center">11.0 ± 29.6</td><td align="center">14.5 ± 34.8</td><td align="char">.186</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean ± SD or No. (%). Boldface indicates a <italic>P</italic> value with statistical significance. AB = arousal burden; AHI = apnea/hypopnoea index; AI = arousal index; CAD = coronary artery disease; CHF = congestive heart failure; DBP = diastolic BP; HTN = hypertension; MI = myocardial infarction; PASE = Physical Activity Scale for Elderly; PLMI = periodic limb movement index; MRR = mean respiratory rate; QTVi = QT variability index; SBP = systolic BP; T90 = time of sleep spent below 90% oxygen saturation; TIA = transient ischemic attack.</p></fn></table-wrap-foot></table-wrap><fig id="fig4"><label>Figure 4</label><caption><p>Cumulative incident function curves compare the competing risk of cardiovascular and noncardiovascular mortality in the men of the first quartile of baseline QTVi. Group 1 represents men whose QTVi values following arousal onset were still in Q1 (QTVi less than –0.96); Group 2 represents participants whose QTVi shifted to upper quartiles (Q2-Q4) following arousal onset. The P value indicates log-rank test results. HR = hazard ratio; QTVi = QT variability index.</p></caption><graphic xlink:href="gr4"/></fig><table-wrap position="float" id="tbl4"><label>Table 4</label><caption><p>All-Cause and Cardiovascular Mortality Risk in Men of the First Quartile of Baseline QTVi</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Variables</th><th colspan="4">All-Cause Mortality<hr/></th><th colspan="4">Cardiovascular Mortality<hr/></th><th colspan="4">Noncardiovascular Mortality<hr/></th></tr><tr><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th></tr><tr><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th><th>HR (95% CI)</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Continuous QTVi</td><td>1.05 (0.95-1.16)</td><td align="char">.306</td><td>0.98 (0.89-1.08)</td><td align="char">.743</td><td>1.18 (0.99-1.41)</td><td align="char">.068</td><td>1.12 (0.93-1.35)</td><td align="char">.217</td><td>1.00 (0.89-1.13)</td><td align="char">.967</td><td>0.92 (0.82-1.04)</td><td align="char">.194</td></tr><tr><td>QTVi greater than –0.96</td><td>1.31 (1.01-1.70)</td><td align="char"><bold>.047</bold></td><td>1.12 (0.86-1.48)</td><td align="char">.391</td><td>2.02 (1.25-3.26)</td><td align="char"><bold>.004</bold></td><td>1.89 (1.14-3.14)</td><td align="char"><bold>.013</bold></td><td>1.08 (0.78-1.49)</td><td align="char">.641</td><td>0.91 (0.65-1.27)</td><td align="char">.579</td></tr></tbody></table><table-wrap-foot><fn><p>Multivariable analysis was adjusted for age, history of stroke, atrial fibrillation, myocardial infarction/coronary artery disease, congestive heart failure, transient ischemic attack, diabetes, hypertension, COPD, asthma and Parkinson disease, mean heart rate, mean respiratory rate, physical activity scale for elderly, systolic and diastolic BPs, time of sleep spent below 90% oxygen saturation, BMI, apnea-hypopnea index, arousal index, average corrected QT, arousal burden, and drink and smoking habit. Boldface indicates a <italic>P</italic> value with statistical significance. QTVi = QT variability index.</p></fn></table-wrap-foot></table-wrap></p>
              </sec>
            </sec>
            <sec id="sec3">
              <title>Discussion</title>
              <p id="p0160">To the best of our knowledge, the current study is the first to show that arousal-related transient changes in ventricular repolarization contribute to high repolarization lability reflected by changes in arousal-related QTVi. Irrespective of the cause of sleep arousal, arousal-related QTVi identified a group of older men at higher risk of long-term all-cause and CVD mortality.</p>
              <p id="p0165">Studies have shown changes in ventricular repolarization in patients with conditions typically associated with increased arousal burden. For example, patients with sleep-disordered breathing have an increased arousal burden, a prolonged QT interval, and increased QT interval variability,<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> and they experience increased rates of premature ventricular contractions, all of which might increase their risk<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> for sudden cardiac death.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Herein, we extend this finding by showing a direct temporal relationship between episodic sleep arousals and transient dynamics in ventricular repolarization. In a detailed beat-to-beat analysis, we found that QT and RR interval variability rapidly increased at arousal onset and gradually decreased subsequently. Of note, the relative increase in RR variability was more pronounced than the QT variability increase, resulting in a transient paradoxical QTVi decrease. Irrespective of the cause of sleep arousal, higher arousal-related QTVi was independently associated with an increased risk of long-term mortality. This further supports the observation by Schmidt et al<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> that QTVi increases in REM sleep predict death from CVD in the Sleep Heart Health Study. We assessed explicitly arousal-related QTVi, which focuses on responses in ventricular repolarization to arousals rather than non-specific QT dynamics during different sleep stages. Although there are no normative data on arousal-related QTVi yet available, and there is considerable variation in QTVi values reported in the literature in general,<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> owing to differences in measurement, an increase in QTVi from –2.33 to 0.43 between the first and third quartiles (<xref rid="fig2" ref-type="fig">Fig 2</xref>) would seem significant. Effect sizes reported in the risk stratification literature are of similar magnitude.</p>
              <p id="p0170">Interestingly, QTVi prior to arousal onset (baseline) was not significantly associated with increased long-term mortality and was comparable between REM and non-REM sleep. The association between arousal-related QTVi and long-term mortality was independent of the baseline QTVi, suggesting the involvement of arousal-related mechanisms. We speculate that arousal-related autonomic and hemodynamic responses may detrimentally affect the heart and transiently expose the individual to increased CV risk during sleep.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Interestingly, arousals induced by simulated obstructive respiratory events in healthy pigs transiently dissociate ventricular electromechanical coupling, creating a dynamic arrhythmogenic substrate during sleep.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> Our data show higher QTVi during respiratory arousals than other types of arousal, indicative of pronounced repolarization lability following respiratory events. The duration of the arousal only marginally affected QTVi.</p>
              <p id="p0175">Frequent arousal results in significant sleep fragmentation and circadian rhythm disturbance. In turn, they contribute to increased CV mortality by various mechanisms involving autonomic nervous system activation, nocturnal BP, and heart rate increases.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Long-term exposure to repeated arousal-related pathophysiological conditions may create a detrimental substrate contributing to CV long-term mortality. QTVi may also represent a risk marker in some patients. Concomitant conditions associated with increased arousal burden, such as sleep-disordered breathing, shift work,<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> or sleep deprivation<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> due to nocturnal noise pollution, have all been shown to increase all-cause and CV mortality. Moreover, irregular sleep duration<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> and timing increase CVD risk independent of traditional CVD risk factors and sleep quality and quantity.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="bib29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> Indeed, participants in the highest QTVi quartile were more likely to report a history of CAD, MI, or congestive heart failure. Thus, the association between elevated QTVi and long-term CV may be caused by excessive sympathetic outflow to the ventricles as part of the normal arousal response<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> or indicate structural heart disease or a combination of both. Because we adjusted the Cox regression model for self-reported CAD/MI and congestive heart failure, excessive sympathetic outflow following arousal is likely to contribute to elevated QTVi and possibly a key driver mediating the relationship with long-term CV mortality. Indeed, the subgroup analysis of men with strong QTVi arousal responses (<xref rid="tbl2" ref-type="table">Table 2</xref>) suggests an essential role of autonomic nervous system activation. The relationship between QT variability and sympathetic outflow has been documented using cardiac noradrenaline spill-over measurement,<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> muscle sympathetic nerve activity, or pharmacologic adrenergic receptor activation.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> In particular, rhythmic repolarization changes are linked with sympathetic drive.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></p>
              <p id="p0180">Several consensuses<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and scientific statements propose a more disease-oriented and pathophysiology-based assessment of sleep-related abnormalities. Extending the continuous effort to improve the evaluation of sleep-disordered breathing severity by incorporating apnea-related hypoxemia<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="bib36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> and heart rate responses,<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> we introduce arousal-related QTVi to quantify cardiac repolarization responses to arousal. QTVi is a robust, established ECG-derived parameter that yields a simple, noninvasive measure of repolarization dynamics predictive of sudden arrhythmia death<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> and could be integrated into analysis software packages to analyze clinical PSGs. In addition, wearable devices<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> that can provide surrogate parameters of arousal burden and ECG recordings during sleep could supply valuable data on periodic repolarization dynamics to apply this approach more widely.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref><sup>,</sup><xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> Whether a routine assessment of arousal-related cardiovascular responses such as arousal-related QTVi improves the clinical evaluation of arousals and results in a better and more tailored sleep arousal-specific risk stratification of a patient<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> remains to be established. In addition, its utility in guiding personalized interventions to reduce arousal-related risks, such as managing the underlying conditions and lifestyle changes, warrants further study.</p>
              <p id="p0185">The current study had certain limitations. Participants were predominately white men and were predominantly older. Hence our findings cannot be extrapolated to women, other races, or younger individuals. Further studies, including men and women, can help delineate the relationship between cardiac arousal response, sex, and mortality. Our observations are based on a single night. Repeated studies over multiple nights will be required to shed light on day-to-day variations and reproducibility. Also, baseline exposure to various conditions was self-reported rather than systematically ascertained through medical records or direct measurement. We did not consider the possible confounding effects of medications and did not examine the cause of arousal. <italic>P</italic> values were not adjusted for multiple testing. In addition, in line with the American Academy of Sleep Medicine scoring rules, cortical but not subcortical arousals were considered. The current study investigated the association between arousal-related QTVi response and mortality. Individual arousal causes were not explicitly modeled, although we adjusted the regression models for arousal burden and common arousal triggers such as sleep-disordered breathing (eg, AHI, time of sleep spent below 90% oxygen saturation). Our observation of transient changes in ventricular repolarization around arousals does not prove a causal relationship.</p>
            </sec>
            <sec id="sec4">
              <title>Interpretation</title>
              <p id="p0190">Sleep arousal-related variability in ventricular repolarization, quantified by QTVi, is associated with long-term all-cause mortality, primarily due to higher CV mortality, in older community-dwelling men. Further intervention studies targeting sleep arousal are warranted to investigate whether sleep arousal-related QTVi represents a modifiable risk marker of underlying disease or a modifiable risk factor.</p>
            </sec>
            <sec id="sec5">
              <title>Funding/Support</title>
              <p id="p0230aas">This study was supported by a grant from the <funding-source id="gs1">Australian Research Council</funding-source> [DP0663345]. The MrOS study and the Study of Osteoporotic Fractures (SOF) are supported by National Institutes of Health (NIH) funding. The following institutes provided support: The National Institute on Aging, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Center for Advancing Translational Sciences, and NIH Roadmap for Medical Research [U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128]. The National Heart, Lung, and Blood Institute provided funding for the MrOS sleep ancillary study [R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and R01 HL070839] and the National Sleep Research Resource [R24-HL-114473]. The SOF sleep study was supported by grants AG021918, AG026720, AG05394, AG05407, AG08415, AR35582, AR35583, AR35584, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1, HL40489, and T32 AG000212-14. S. R. was supported in part by the NIH [R35HL135818].</p>
            </sec>
            <sec id="sec6">
              <title>Financial/Nonfinancial Disclosures</title>
              <p id="p0235edfr">None declared.</p>
            </sec>
          </body>
          <back>
            <ref-list id="cebib0010">
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <element-citation publication-type="book" id="sref1">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Iber</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Ancoli-Israel</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Chesson</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Quan</surname>
                      <given-names>S.F.</given-names>
                    </name>
                  </person-group>
                  <part-title>The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications</part-title>
                  <year>2007</year>
                  <publisher-name>American Academy of Sleep Medicine</publisher-name>
                </element-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <element-citation publication-type="journal" id="sref2">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shahrbabaki</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hartmann</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Redline</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women</article-title>
                  <source>Eur Heart J</source>
                  <volume>21</volume>
                  <year>2021</year>
                  <fpage>2088</fpage>
                  <lpage>2099</lpage>
                </element-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <element-citation publication-type="journal" id="sref3">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cowie</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Redline</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Somers</surname>
                      <given-names>V.K.</given-names>
                    </name>
                    <name>
                      <surname>Simonds</surname>
                      <given-names>A.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sleep disordered breathing and cardiovascular disease: JACC State-of-the-Art Review</article-title>
                  <source>J Am Coll Cardiol</source>
                  <volume>78</volume>
                  <issue>6</issue>
                  <year>2021</year>
                  <fpage>608</fpage>
                  <lpage>624</lpage>
                  <pub-id pub-id-type="pmid">34353537</pub-id>
                </element-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <element-citation publication-type="journal" id="sref4">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Floras</surname>
                      <given-names>J.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sympathetic nervous system in patients with sleep related breathing disorders</article-title>
                  <source>Cur Hypertension Rev</source>
                  <volume>12</volume>
                  <issue>1</issue>
                  <year>2016</year>
                  <fpage>18</fpage>
                  <lpage>26</lpage>
                </element-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <element-citation publication-type="journal" id="sref5">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Catcheside</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Assessment and interpretation of sleep disordered breathing severity in cardiology: clinical implications and perspectives</article-title>
                  <source>Int J Cardiol</source>
                  <volume>271</volume>
                  <year>2018</year>
                  <fpage>281</fpage>
                  <lpage>288</lpage>
                  <pub-id pub-id-type="pmid">30049491</pub-id>
                </element-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <element-citation publication-type="journal" id="sref6">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oosterhoff</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Tereshchenko</surname>
                      <given-names>L.G.</given-names>
                    </name>
                    <name>
                      <surname>van der Heyden</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Short-term variability of repolarisation predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: a comparison with QT variability index</article-title>
                  <source>Heart Rhythm</source>
                  <volume>8</volume>
                  <issue>10</issue>
                  <year>2011</year>
                  <fpage>1584</fpage>
                  <lpage>1590</lpage>
                  <pub-id pub-id-type="pmid">21699842</pub-id>
                </element-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <element-citation publication-type="journal" id="sref7">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Piccirillo</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Magrì</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Matera</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study</article-title>
                  <source>Eur Heart J</source>
                  <volume>28</volume>
                  <issue>11</issue>
                  <year>2007</year>
                  <fpage>1344</fpage>
                  <lpage>1350</lpage>
                  <pub-id pub-id-type="pmid">17101636</pub-id>
                </element-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <element-citation publication-type="journal" id="sref8">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karisik</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Template adaptation of 2D quasi-periodic data using a soft-assign localized correspondence matrix</article-title>
                  <source>IEEE T Signal Process</source>
                  <volume>69</volume>
                  <year>2021</year>
                  <fpage>826</fpage>
                  <lpage>836</lpage>
                </element-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <element-citation publication-type="journal" id="sref9">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Malberg</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zaunseder</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Iterative two-dimensional signal warping—towards a generalized approach for adaption of one-dimensional signals</article-title>
                  <source>Biomed Signal Process Control</source>
                  <volume>43</volume>
                  <year>2018</year>
                  <fpage>311</fpage>
                  <lpage>319</lpage>
                </element-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <element-citation publication-type="journal" id="sref10">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Orwoll</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Blank</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Barrett-Connor</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Design and baseline characteristics of the Osteoporotic Fractures in Men (MrOS) study—a large observational study of the determinants of fracture in older men</article-title>
                  <source>Contemp Clin Trials</source>
                  <volume>26</volume>
                  <issue>5</issue>
                  <year>2005</year>
                  <fpage>569</fpage>
                  <lpage>585</lpage>
                  <pub-id pub-id-type="pmid">16084776</pub-id>
                </element-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <element-citation publication-type="journal" id="sref11">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blank</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Cawthon</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Carrion-Petersen</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Overview of recruitment for the Osteoporotic Fractures in Men study (MrOS)</article-title>
                  <source>Contemp Clin Trials</source>
                  <volume>26</volume>
                  <issue>5</issue>
                  <year>2005</year>
                  <fpage>557</fpage>
                  <lpage>568</lpage>
                  <pub-id pub-id-type="pmid">16085466</pub-id>
                </element-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <mixed-citation publication-type="other" id="sref12">NCT. ClinicalTrials.gov Identifier: NCT00070681.</mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <element-citation publication-type="journal" id="sref13">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mehra</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Blackwell</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Osteoporotic Fractures in Men Study. Prevalence and correlates of sleep-disordered breathing in older men: osteoporotic fractures in men sleep study</article-title>
                  <source>J Am Geriatr Soc</source>
                  <volume>55</volume>
                  <issue>9</issue>
                  <year>2007</year>
                  <fpage>1356</fpage>
                  <lpage>1364</lpage>
                  <pub-id pub-id-type="pmid">17767677</pub-id>
                </element-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <element-citation publication-type="journal" id="sref14">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women</article-title>
                  <source>Eur Respir J</source>
                  <volume>54</volume>
                  <issue>1</issue>
                  <year>2019</year>
                  <object-id pub-id-type="publisher-id">1802175</object-id>
                </element-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <element-citation publication-type="journal" id="sref15">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koo</surname>
                      <given-names>B.B.</given-names>
                    </name>
                    <name>
                      <surname>Blackwell</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ancoli-Israel</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Stefanick</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Redline</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Association of incident cardiovascular disease with periodic limb movements during sleep in older men</article-title>
                  <source>Circulation</source>
                  <volume>124</volume>
                  <issue>11</issue>
                  <year>2011</year>
                  <fpage>1223</fpage>
                  <lpage>1231</lpage>
                  <pub-id pub-id-type="pmid">21859975</pub-id>
                </element-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <element-citation publication-type="journal" id="sref16">
                  <person-group person-group-type="author">
                    <name>
                      <surname>May</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>May</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Bena</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Osteoporotic Fractures in Men (MrOS) Study Group. Individual periodic limb movements with arousal are temporally associated with nonsustained ventricular tachycardia: a case-crossover analysis</article-title>
                  <source>Sleep</source>
                  <volume>42</volume>
                  <issue>11</issue>
                  <year>2019</year>
                  <fpage>zsz165</fpage>
                  <pub-id pub-id-type="pmid">31585012</pub-id>
                </element-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <element-citation publication-type="journal" id="sref17">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Porta</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Malberg</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zaunseder</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Two-dimensional warping for one-dimensional signals—conceptual framework and application to ECG processing</article-title>
                  <source>IEEE T Signal Process</source>
                  <volume>62</volume>
                  <issue>21</issue>
                  <year>2014</year>
                  <fpage>5577</fpage>
                  <lpage>5588</lpage>
                </element-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <element-citation publication-type="journal" id="sref18">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hasan</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Abbott</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects</article-title>
                  <source>Ann Noninvasive Electrocardiol</source>
                  <volume>17</volume>
                  <issue>3</issue>
                  <year>2012</year>
                  <fpage>195</fpage>
                  <lpage>203</lpage>
                  <pub-id pub-id-type="pmid">22816538</pub-id>
                </element-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <element-citation publication-type="journal" id="sref19">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Immanuel</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling man</article-title>
                  <source>Eur Heart J</source>
                  <volume>41</volume>
                  <year>2020</year>
                  <fpage>533</fpage>
                  <lpage>541</lpage>
                  <pub-id pub-id-type="pmid">30590586</pub-id>
                </element-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <element-citation publication-type="journal" id="sref20">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Catcheside</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Variability of QT interval duration in obstructive sleep apnea: an indicator of disease severity</article-title>
                  <source>Sleep</source>
                  <volume>31</volume>
                  <issue>7</issue>
                  <year>2008</year>
                  <fpage>959</fpage>
                  <lpage>966</lpage>
                  <pub-id pub-id-type="pmid">18652091</pub-id>
                </element-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <element-citation publication-type="journal" id="sref21">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rossi</surname>
                      <given-names>V.A.</given-names>
                    </name>
                    <name>
                      <surname>Stoewhas</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Camen</surname>
                      <given-names>G.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarisation: data from a randomized controlled trial</article-title>
                  <source>Eur Heart J</source>
                  <volume>33</volume>
                  <year>2012</year>
                  <fpage>2206</fpage>
                  <lpage>2212</lpage>
                  <pub-id pub-id-type="pmid">22453648</pub-id>
                </element-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <element-citation publication-type="journal" id="sref22">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryan</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Usui</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Floras</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Bradley</surname>
                      <given-names>T.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea</article-title>
                  <source>Thorax</source>
                  <volume>60</volume>
                  <year>2005</year>
                  <fpage>781</fpage>
                  <lpage>785</lpage>
                  <pub-id pub-id-type="pmid">15994252</pub-id>
                </element-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <element-citation publication-type="journal" id="sref23">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Penzel</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Malberg</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zaunseder</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Nocturnal ventricular repolarisation lability predicts cardiovascular mortality in the Sleep Heart Health Study</article-title>
                  <source>Am J Physiol Heart Circ Physiol</source>
                  <volume>316</volume>
                  <issue>3</issue>
                  <year>2019</year>
                  <fpage>H495</fpage>
                  <lpage>H505</lpage>
                  <pub-id pub-id-type="pmid">30550351</pub-id>
                </element-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <element-citation publication-type="journal" id="sref24">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Porta</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Vos</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology</article-title>
                  <source>Europace</source>
                  <volume>18</volume>
                  <issue>6</issue>
                  <year>2016</year>
                  <fpage>925</fpage>
                  <lpage>944</lpage>
                  <pub-id pub-id-type="pmid">26823389</pub-id>
                </element-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <element-citation publication-type="journal" id="sref25">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linz</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Sattler</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Flethøj</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Arrhythmogenic mechanisms of acute obstructive respiratory events in a porcine model of drug-induced long QT</article-title>
                  <source>Heart Rhythm</source>
                  <volume>18</volume>
                  <issue>8</issue>
                  <year>2021</year>
                  <fpage>1384</fpage>
                  <lpage>1391</lpage>
                  <pub-id pub-id-type="pmid">33722764</pub-id>
                </element-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <element-citation publication-type="journal" id="sref26">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease</article-title>
                  <source>Eur Heart J</source>
                  <volume>42</volume>
                  <issue>40</issue>
                  <year>2021</year>
                  <fpage>4180</fpage>
                  <lpage>4188</lpage>
                  <pub-id pub-id-type="pmid">34374755</pub-id>
                </element-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <element-citation publication-type="journal" id="sref27">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kröller-Schön</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Daiber</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Steven</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation</article-title>
                  <source>Eur Heart J</source>
                  <volume>39</volume>
                  <issue>38</issue>
                  <year>2018</year>
                  <fpage>3528</fpage>
                  <lpage>3539</lpage>
                  <pub-id pub-id-type="pmid">29905797</pub-id>
                </element-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <element-citation publication-type="journal" id="sref28">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bangdiwala</surname>
                      <given-names>S.I.</given-names>
                    </name>
                    <name>
                      <surname>Rangarajan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116,632 people from 21 countries</article-title>
                  <source>Eur Heart J</source>
                  <volume>40</volume>
                  <issue>20</issue>
                  <year>2019</year>
                  <fpage>1620</fpage>
                  <lpage>1629</lpage>
                  <pub-id pub-id-type="pmid">30517670</pub-id>
                </element-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <element-citation publication-type="journal" id="sref29">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reinhard</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Plappert</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Zeman</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prognostic impact of sleep duration and sleep efficiency on mortality in patients with chronic heart failure</article-title>
                  <source>Sleep Med</source>
                  <volume>14</volume>
                  <issue>6</issue>
                  <year>2013</year>
                  <fpage>502</fpage>
                  <lpage>509</lpage>
                  <pub-id pub-id-type="pmid">23628241</pub-id>
                </element-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <element-citation publication-type="journal" id="sref30">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spiesshoefer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Skobel</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                    <collab>on behalf of the German Cardiac Society Working Group on Sleep Disordered Breathing Ag-Deutsche Gesellschaft Für Kardiologie Herz Und Kreislaufforschung E V</collab>
                  </person-group>
                  <article-title>Sleep—the yet underappreciated player in cardiovascular diseases: a clinical review from the German Cardiac Society Working Group on Sleep Disordered Breathing</article-title>
                  <source>Eur J Prev Cardiol</source>
                  <volume>28</volume>
                  <issue>2</issue>
                  <year>2019</year>
                  <fpage>189</fpage>
                  <lpage>200</lpage>
                  <pub-id pub-id-type="pmid">33611525</pub-id>
                </element-citation>
              </ref>
              <ref id="bib31">
                <label>31</label>
                <element-citation publication-type="journal" id="sref31">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Somers</surname>
                      <given-names>V.K.</given-names>
                    </name>
                    <name>
                      <surname>Dyken</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Mark</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Abboud</surname>
                      <given-names>F.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sympathetic-nerve activity during sleep in normal subjects</article-title>
                  <source>N Engl J Med</source>
                  <volume>328</volume>
                  <issue>5</issue>
                  <year>1993</year>
                  <fpage>303</fpage>
                  <lpage>307</lpage>
                  <pub-id pub-id-type="pmid">8419815</pub-id>
                </element-citation>
              </ref>
              <ref id="bib32">
                <label>32</label>
                <element-citation publication-type="journal" id="sref32">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schlaich</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Nalivaiko</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relation between QT interval variability and cardiac sympathetic activity in hypertension</article-title>
                  <source>Am J Physiol Heart Circ Physiol</source>
                  <volume>300</volume>
                  <issue>4</issue>
                  <year>2011</year>
                  <fpage>H1412</fpage>
                  <lpage>H1417</lpage>
                  <pub-id pub-id-type="pmid">21257917</pub-id>
                </element-citation>
              </ref>
              <ref id="bib33">
                <label>33</label>
                <element-citation publication-type="journal" id="sref33">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rizas</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Nieminen</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Barthel</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction</article-title>
                  <source>J Clin Invest</source>
                  <volume>124</volume>
                  <issue>4</issue>
                  <year>2014</year>
                  <fpage>1770</fpage>
                  <lpage>1780</lpage>
                  <pub-id pub-id-type="pmid">24642467</pub-id>
                </element-citation>
              </ref>
              <ref id="bib34">
                <label>34</label>
                <element-citation publication-type="journal" id="sref34">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sampedro-Puente</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Fernandez-Bes</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Porter</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>van Duijvenboden</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Taggart</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Pueyo</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms underlying interactions between low-frequency oscillations and beat-to-beat variability of cellular ventricular repolarization in response to sympathetic stimulation: implications for arrhythmogenesis</article-title>
                  <source>Front Physiol</source>
                  <volume>10</volume>
                  <year>2019</year>
                  <fpage>916</fpage>
                  <pub-id pub-id-type="pmid">31427979</pub-id>
                </element-citation>
              </ref>
              <ref id="bib35">
                <label>35</label>
                <element-citation publication-type="journal" id="sref35">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baker-Smith</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Isaiah</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Melendres</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>American Heart Association Athero, Hypertension and Obesity in the Young Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young. Sleep-disordered breathing and cardiovascular disease in children and adolescents: a scientific statement from the American Heart Association</article-title>
                  <source>J Am Heart Assoc</source>
                  <year>2021</year>
                  <object-id pub-id-type="publisher-id">e022427</object-id>
                </element-citation>
              </ref>
              <ref id="bib36">
                <label>36</label>
                <element-citation publication-type="journal" id="sref36">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Azarbarzin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sands</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Stone</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study</article-title>
                  <source>Eur Heart J</source>
                  <volume>40</volume>
                  <issue>14</issue>
                  <year>2019</year>
                  <fpage>1149</fpage>
                  <lpage>1157</lpage>
                  <pub-id pub-id-type="pmid">30376054</pub-id>
                </element-citation>
              </ref>
              <ref id="bib37">
                <label>37</label>
                <element-citation publication-type="journal" id="sref37">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Loffler</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Sanders</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Low prognostic value of novel nocturnal metrics in patients with OSA and high cardiovascular event risk: post hoc analyses of the SAVE Study</article-title>
                  <source>Chest</source>
                  <volume>158</volume>
                  <issue>6</issue>
                  <year>2020</year>
                  <fpage>2621</fpage>
                  <lpage>2631</lpage>
                  <pub-id pub-id-type="pmid">32679239</pub-id>
                </element-citation>
              </ref>
              <ref id="bib38">
                <label>38</label>
                <element-citation publication-type="journal" id="sref38">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Azarbarzin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sands</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Younes</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The sleep apnea-specific pulse-rate response predicts cardiovascular morbidity and mortality</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <volume>203</volume>
                  <issue>12</issue>
                  <year>2021</year>
                  <fpage>1546</fpage>
                  <lpage>1555.33</lpage>
                  <pub-id pub-id-type="pmid">33406013</pub-id>
                </element-citation>
              </ref>
              <ref id="bib39">
                <label>39</label>
                <element-citation publication-type="journal" id="sref39">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yaghini Bonabi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>El-Hamad</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Müller</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Recording duration and short-term reproducibility of heart rate and QT interval variability in patients with myocardial infarction</article-title>
                  <source>Physiol Meas</source>
                  <volume>37</volume>
                  <issue>11</issue>
                  <year>2016</year>
                  <fpage>1925</fpage>
                  <lpage>1933</lpage>
                  <pub-id pub-id-type="pmid">27681306</pub-id>
                </element-citation>
              </ref>
              <ref id="bib40">
                <label>40</label>
                <element-citation publication-type="journal" id="sref40">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giudicessi</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Schram</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bos</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Artificial intelligence-enabled assessment of the heart rate corrected QT interval using a mobile electrocardiogram device</article-title>
                  <source>Circulation</source>
                  <volume>143</volume>
                  <issue>13</issue>
                  <year>2021</year>
                  <fpage>1274</fpage>
                  <lpage>1286</lpage>
                  <pub-id pub-id-type="pmid">33517677</pub-id>
                </element-citation>
              </ref>
              <ref id="bib41">
                <label>41</label>
                <element-citation publication-type="journal" id="sref41">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rizas</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Doller</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Hamm</surname>
                      <given-names>W.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Periodic repolarization dynamics as a risk predictor after myocardial infarction: prospective validation study</article-title>
                  <source>Heart Rhythm</source>
                  <volume>16</volume>
                  <issue>8</issue>
                  <year>2019</year>
                  <fpage>1223</fpage>
                  <lpage>1231</lpage>
                  <pub-id pub-id-type="pmid">30818092</pub-id>
                </element-citation>
              </ref>
              <ref id="bib42">
                <label>42</label>
                <element-citation publication-type="journal" id="sref42">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bauer</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Klemm</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rizas</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study</article-title>
                  <source>Lancet</source>
                  <volume>394</volume>
                  <issue>10206</issue>
                  <year>2019</year>
                  <fpage>1344</fpage>
                  <lpage>1351</lpage>
                  <pub-id pub-id-type="pmid">31488371</pub-id>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="appsec1" sec-type="supplementary-material">
              <title>Supplementary Data</title>
              <p id="p0225">
                <supplementary-material content-type="local-data" id="mmc1">
                  <caption>
                    <title>e-Online Data</title>
                  </caption>
                  <media xlink:href="mmc1.docx"/>
                </supplementary-material>
              </p>
            </sec>
            <ack id="ack0010">
              <title>Acknowledgments</title>
              <p id="p0195"><bold>Author contributions:</bold> All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. S. S. S., D. L. and M. B. served as principal authors. All authors contributed substantially to the study design, data analysis and interpretation, and the writing of the manuscript.</p>
              <p id="p0210"><bold>Role</bold><bold>of</bold><bold>sponsors:</bold> The study sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.</p>
              <p id="p0215"><bold>Data sharing:</bold> All individual participant data generated during this study will be made available at the MrOS online (<ext-link ext-link-type="uri" xlink:href="https://mrosdata.sfcc-cpmc.net/" id="intref0015">https://mrosdata.sfcc-cpmc.net/</ext-link>) and <ext-link ext-link-type="uri" xlink:href="http://sleepdata.org" id="intref0020">sleepdata.org</ext-link> websites.</p>
              <p id="p0220"><bold>Additional information:</bold> The <xref rid="appsec1" ref-type="sec">e-Figures</xref> and <xref rid="appsec1" ref-type="sec">e-Tables</xref> are available online under “<xref rid="appsec1" ref-type="sec">Supplementary Data</xref>.”</p>
            </ack>
            <fn-group>
              <fn id="d35e1471">
                <p id="ntpara0010">Drs Shahrbabaki and Linz are joint first authors.</p>
              </fn>
            </fn-group>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
